Carla S Coffin, Sarah Haylock-Jacobs, Karen Doucette, Alnoor Ramji, Hin Hin Ko, David K Wong, Magdy Elkhashab, Robert Bailey, Julia Uhanova, Gerald Minuk, Keith Tsoi, Alexander Wong, Mang M Ma, Edward Tam, Mayur Brahmania, Carmine Nudo, Julie Zhu, Christopher F Lowe, Carla Osiowy, B Cord Lethebe, Stephen E Congly, Eric K H Chan, Angelina Villasis-Keever, Urbano Sbarigia, Curtis L Cooper, Scott Fung
BACKGROUND: Hepatitis B surface antigen (HBsAg) loss is associated with improved clinical outcomes for individuals with chronic hepatitis B (CHB); however, the effects of varying HBsAg levels on clinical outcomes in diverse cohorts are understudied. METHODS: In this cross-sectional, multicentre, retrospective study, the data on adult subjects enrolled in the Canadian HBV Network with CHB seen from 1 January 2012 to 30 January 2021 with the treatment and virologic data within 1 year of HBsAg testing were analyzed...
November 29, 2022: Viruses